Abstract

The clinical considerations include discussion on:

  • administration
  • Vaccination of persons with prior SARSCoV-2 infection or exposure
  • Vaccination of special populations
  • Patient vaccine counseling
  • Contraindications and precautions
  • Interpretation of SARS-CoV-2 test results in vaccinated person

These  considerations have been presented at the ACIP extraordinary meeting on December 12, 2020.

Background paper Americas United States of America Pfizer-BioNTech vaccine COVID-19